References
-
1
Bosch J, Thabut D, Bendtsen F. et al .
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double blind trial.
Gastroenterology.
2004;
127
1123-1130
-
2
Ejlersen E, Melsen T, Ingerslev J. et al .
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from esophageal varices.
Scand J Gastroenterol.
2001;
36
1081-1085
-
3
Romero-Castro R, Jiménez-Sáenz M, Pellicer-Bautista F. et al .
Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices.
Clin Gastroenterol Hepatol.
2004;
2
78-84
-
4
Pavese P, Bonadona A, Beaubien J. et al .
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
Can J Anesth.
2005;
52
26-29
-
5
Atkison P R, Jardine L, Williams S. et al .
Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
Transplant Proc.
2005;
37
1091-1093
-
6
Levi M, Peters M, Buller H R.
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
Crit Care Med.
2005;
33
883-890
-
7
De la Pena J, Brullet E, Sanchez-Hernandez E. et al .
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
Hepatology.
2005;
41
572-578
-
8
Lo G H, Lai K H, Cheng J S. et al .
Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective randomized trial.
Hepatology.
2000;
32
461-465
-
9
Sarin S K, Wadhawan M, Agarwal S R. et al .
Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding.
Am J Gastroenterol.
2005;
100
797-804
-
10
Lo G H, Chen W C, Chen M H. et al .
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.
Gastrointest Endosc.
2004;
59
333-338
-
11
Merkel C, Marin R, Angeli P. et al .
A placebo controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.
Gastroenterology.
2004;
127
476-484
-
12
Mata A, Bordas J M, Feu F. et al .
Wireless capsule endoscopy in patients with obscure gastrointestinal bleeding: a comparative study with push enteroscopy.
Aliment Pharmacol Ther.
2004;
20
189-194
-
13
Selby W.
Can clinical features predict the likelihood of finding abnormalities when using capsule endoscopy in patients with GI bleeding of obscure origin?.
Gastrointest Endosc.
2004;
59
782-787
-
14
Jones B H, Fleischer D E, Sharma V K. et al .
Yield of repeat wireless video capsule endoscopy in patients with obscure gastrointestinal bleeding.
Am J Gastroenterol.
2005;
100
1058-1064
-
15
Yamamoto H, Kita H, Sunada K. et al .
Clinical outcomes of double balloon endoscopy for the diagnosis and treatment of small intestinal diseases.
Clin Gastroenterol Hepatol.
2004;
2
1010-1016
-
16
Matsumoto T, Esaki M, Moriyama T. et al .
Comparison of capsule endoscopy and enteroscopy with the double-balloon method in patients with obscure bleeding and polyposis.
Endoscopy.
2005;
37
827-832
-
17
Park C H, Lee S J, Park J H. et al .
Optimal injection volume of epinephrine for endoscopic prevention of recurrent peptic ulcer bleeding.
Gastrointest Endosc.
2004;
60
875-880
-
18
Park C H, Joo Y E, Kim H S. et al .
A prospective randomized trial comparing mechanical methods of hemostasis plus epinephrine injection to epinephrine injection alone for bleeding peptic ulcer.
Gastrointest Endosc.
2004;
60
173-179
-
19
Bianco M A, Rotondano G, Marmo R. et al .
Combined epinephrine and bipolar coagulation vs. bipolar probe coagulation alone for bleeding peptic ulcer: a randomized, controlled trial.
Gastrointest Endosc.
2004;
60
910-915
-
20
Thomopoulos K C, Theocharis G J, Vagenas K A. et al .
Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel.
Scand J Gastroenterol.
2004;
39
600-604
-
21
Amano Y, Moriyama N, Suetsugu H. et al .
Which type of non-bleeding visible vessels in gastric peptic ulcers should be treated by endoscopic hemostasis?.
J Gastroenterol Hepatol.
2004;
19
13-17
D. K. Bhasin, M. D.
Dept. of Gastroenterology
Postgraduate Institute of Medical Education and Research · Chandigarh 160 012 · India
Fax: +91-172-2744401
Email: deepakkbhasin@gmail.com
